The potential risk factors for LACNP remain unclear, which may include the course of diabetes, levels of blood glucose and HbAlc, hypertension and arteriosclerosis, prior intravitreal treatment of anti-VEGF agents, etc [12]. This evidence concerns the gene VEGFA and diabetes mellitus.